About Generate Biomedicines
Generate Biomedicines focuses on creating new medicines using a method called generative biology, which combines machine learning and biological engineering. The company studies millions of proteins to learn how nature encodes their functions, and then applies this knowledge to design new medicines with specific therapeutic effects. Their main product, The Generate Platform, allows for the rapid production of medicines across various therapeutic areas, making the drug discovery process more efficient compared to traditional methods. Unlike many competitors, Generate Biomedicines emphasizes a proactive approach to medicine creation, aiming to democratize access to biotherapeutics. The company's goal is to expand its capabilities in generating and testing proteins, with a commitment to providing innovative therapeutic solutions.